HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
3.520
+0.060 (1.73%)
Sep 18, 2025, 1:42 PM EDT - Market open

HeartSciences Statistics

Total Valuation

HeartSciences has a market cap or net worth of $9.32 million. The enterprise value is $8.32 million.

Market Cap9.32M
Enterprise Value 8.32M

Important Dates

The last earnings date was Thursday, September 11, 2025, after market close.

Earnings Date Sep 11, 2025
Ex-Dividend Date n/a

Share Statistics

HeartSciences has 2.65 million shares outstanding. The number of shares has increased by 105.27% in one year.

Current Share Class 2.65M
Shares Outstanding 2.65M
Shares Change (YoY) +105.27%
Shares Change (QoQ) +21.72%
Owned by Insiders (%) 3.23%
Owned by Institutions (%) 4.18%
Float 2.56M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1,465.77
Forward PS n/a
PB Ratio 2.51
P/TBV Ratio 6.01
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1,330.51
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.47, with a Debt / Equity ratio of 0.62.

Current Ratio 1.47
Quick Ratio 0.93
Debt / Equity 0.62
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -12.32

Financial Efficiency

Return on equity (ROE) is -193.24% and return on invested capital (ROIC) is -84.67%.

Return on Equity (ROE) -193.24%
Return on Assets (ROA) -69.65%
Return on Invested Capital (ROIC) -84.67%
Return on Capital Employed (ROCE) -238.15%
Revenue Per Employee $417
Profits Per Employee -$584,569
Employee Count15
Asset Turnover 0.00
Inventory Turnover 0.00

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +21.88% in the last 52 weeks. The beta is 2.59, so HeartSciences's price volatility has been higher than the market average.

Beta (5Y) 2.59
52-Week Price Change +21.88%
50-Day Moving Average 3.61
200-Day Moving Average 3.52
Relative Strength Index (RSI) 52.25
Average Volume (20 Days) 86,750

Short Selling Information

The latest short interest is 85,155, so 3.22% of the outstanding shares have been sold short.

Short Interest 85,155
Short Previous Month 98,701
Short % of Shares Out 3.22%
Short % of Float 3.32%
Short Ratio (days to cover) 0.83

Income Statement

In the last 12 months, HeartSciences had revenue of $6,250 and -$8.77 million in losses. Loss per share was -$8.20.

Revenue6,250
Gross Profit 3,610
Operating Income -8.15M
Pretax Income -6.61M
Net Income -8.77M
EBITDA -8.12M
EBIT -8.15M
Loss Per Share -$8.20
Full Income Statement

Balance Sheet

The company has $2.79 million in cash and $1.95 million in debt, giving a net cash position of $845,368 or $0.32 per share.

Cash & Cash Equivalents 2.79M
Total Debt 1.95M
Net Cash 845,368
Net Cash Per Share $0.32
Equity (Book Value) 3.14M
Book Value Per Share 1.38
Working Capital 1.40M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.35 million and capital expenditures -$3,157, giving a free cash flow of -$7.35 million.

Operating Cash Flow -7.35M
Capital Expenditures -3,157
Free Cash Flow -7.35M
FCF Per Share -$2.78
Full Cash Flow Statement

Margins

Gross Margin 57.76%
Operating Margin -130,416.37%
Pretax Margin -140,296.54%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

HeartSciences does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -105.27%
Shareholder Yield -105.27%
Earnings Yield -95.72%
FCF Yield -80.24%

Analyst Forecast

The average price target for HeartSciences is $13.00, which is 269.33% higher than the current price. The consensus rating is "Strong Buy".

Price Target $13.00
Price Target Difference 269.33%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on May 17, 2024. It was a reverse split with a ratio of 1:100.

Last Split Date May 17, 2024
Split Type Reverse
Split Ratio 1:100

Scores

HeartSciences has an Altman Z-Score of -20.27 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -20.27
Piotroski F-Score 1